首页 > 最新文献

International journal of epidemiology最新文献

英文 中文
Software Application Profile: TriplotGUI, a molecular epidemiology toolbox for investigating associations between exposures, omics, and outcomes. 软件应用简介:TriplotGUI,一个分子流行病学工具箱,用于调查暴露、组学和结果之间的关系。
IF 5.9 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-10-14 DOI: 10.1093/ije/dyaf203
Yingxiao Yan, Anton Ribbenstedt, Tessa Schillemans, Carl Brunius
{"title":"Software Application Profile: TriplotGUI, a molecular epidemiology toolbox for investigating associations between exposures, omics, and outcomes.","authors":"Yingxiao Yan, Anton Ribbenstedt, Tessa Schillemans, Carl Brunius","doi":"10.1093/ije/dyaf203","DOIUrl":"10.1093/ije/dyaf203","url":null,"abstract":"","PeriodicalId":14147,"journal":{"name":"International journal of epidemiology","volume":"54 6","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12677948/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145677399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cohort Profile Update: The OsteoLaus study. 队列概况更新:OsteoLaus研究。
IF 5.9 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-10-14 DOI: 10.1093/ije/dyaf179
Enisa Shevroja, Colin Vendrami, Guillaume Gatineau, Elena Gonzalez Rodriguez, Olivier Lamy, Didier Hans
{"title":"Cohort Profile Update: The OsteoLaus study.","authors":"Enisa Shevroja, Colin Vendrami, Guillaume Gatineau, Elena Gonzalez Rodriguez, Olivier Lamy, Didier Hans","doi":"10.1093/ije/dyaf179","DOIUrl":"10.1093/ije/dyaf179","url":null,"abstract":"","PeriodicalId":14147,"journal":{"name":"International journal of epidemiology","volume":"54 6","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145482059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interpretation of lipidomics associations with type 2 diabetes: the importance of lipoprotein mediation. 脂质组学与2型糖尿病相关性的解释:脂蛋白介导的重要性
IF 5.9 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-10-14 DOI: 10.1093/ije/dyaf202
Mika Ala-Korpela, Siyu Zhao, Corey Giles, Kevin Huynh, Johannes Kettunen, Peter J Meikle, Ville-Petteri Mäkinen
{"title":"Interpretation of lipidomics associations with type 2 diabetes: the importance of lipoprotein mediation.","authors":"Mika Ala-Korpela, Siyu Zhao, Corey Giles, Kevin Huynh, Johannes Kettunen, Peter J Meikle, Ville-Petteri Mäkinen","doi":"10.1093/ije/dyaf202","DOIUrl":"https://doi.org/10.1093/ije/dyaf202","url":null,"abstract":"","PeriodicalId":14147,"journal":{"name":"International journal of epidemiology","volume":"54 6","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145587301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-acute non-specific symptoms following COVID-19 vaccination: a Danish population-based study COVID-19疫苗接种后急性后非特异性症状:一项基于丹麦人群的研究
IF 7.7 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-10-10 DOI: 10.1093/ije/dyaf173
Christina Bisgaard Jensen, Kristoffer Torp Hansen, Bodil Hammer Bech, Stefan Nygaard Hansen, Henrik Nielsen, Charlotte Ulrikka Rask, Per Fink, Thomas Meinertz Dantoft, Torben Jørgensen, Jeremy A Labrecque, Sanne Møller Thysen, Dorte Rytter
Background Post-acute non-specific symptoms such as headaches, muscular pain, and fatigue are frequently reported following COVID-19 vaccination, raising concerns about adverse events. As vaccine-hesitant individuals may be more likely to experience symptoms of vaccines, this study investigates whether COVID-19 vaccination increases the odds of post-acute non-specific symptoms, stratified by COVID-19 vaccine hesitancy. Methods This longitudinal study uses repeated measurements from the BiCoVac cohort—a random sample of 913 116 Danish citizens aged 16–65 years. Data were collected through national registers and questionnaires (May 2021–June 2022). Non-specific symptoms were identified by using the 25-item Bodily Distress Syndrome checklist and analysed by using logistic and linear regression models comparing vaccinated and unvaccinated individuals. Models were fitted with robust standard errors and inverse probability of selection weights. Results A total of 132 776 observations were collected from 61 316 COVID-19 vaccine-unconcerned individuals, 52 325 observations from 25 272 COVID-19 vaccine-sceptical individuals, and 10 242 observations from 5064 COVID-19 vaccine-concerned individuals. Among the vaccine-unconcerned individuals, those vaccinated had lower odds of most symptoms compared with unvaccinated individuals >4 weeks post-vaccination [e.g. muscular pain: odds ratio (OR) = 0.56, 95% confidence interval (CI): 0.47–0.68]. A similar tendency was found for vaccine-sceptical individuals, although with attenuated estimates. Conversely, among vaccine-concerned individuals, we observed a tendency for higher odds of most symptoms >4 weeks post-vaccination compared with unvaccinated individuals (e.g. muscular pain: OR = 1.23, 95% CI: 0.91–1.67). Conclusion For most individuals aged 16–65 years, we found no evidence of post-acute symptoms after COVID-19 vaccination. Vaccinated vaccine-concerned individuals were, however, more likely to report most symptoms, potentially due to reporting bias or nocebo effects.
背景:在COVID-19疫苗接种后经常报告急性后非特异性症状,如头痛、肌肉疼痛和疲劳,这引起了对不良事件的关注。由于疫苗犹豫的个体可能更容易出现疫苗症状,本研究调查了COVID-19疫苗接种是否会增加急性后非特异性症状的几率,并按COVID-19疫苗犹豫分层。方法:这项纵向研究使用了来自BiCoVac队列的重复测量数据,该队列随机抽样了913116名年龄在16-65岁之间的丹麦公民。通过国家登记和问卷调查(2021年5月至2022年6月)收集数据。使用25项身体痛苦综合征检查表确定非特异性症状,并通过比较接种疫苗和未接种疫苗的个体使用logistic和线性回归模型进行分析。模型具有鲁棒标准误差和逆概率选择权值。结果共收集61 316例未关注COVID-19疫苗个体的观察结果132 776条,25 272例怀疑COVID-19疫苗个体的观察结果52 325条,5064例关注COVID-19疫苗个体的观察结果10 242条。在未接种疫苗的个体中,与未接种疫苗的个体相比,接种疫苗的个体出现大多数症状的几率较低。接种疫苗后4周[例如肌肉疼痛:优势比(OR) = 0.56, 95%可信区间(CI): 0.47-0.68]。在对疫苗持怀疑态度的个体中也发现了类似的趋势,尽管估计值有所降低。相反,在接种疫苗的个体中,我们观察到大多数症状的发生率较高的趋势。接种疫苗后4周与未接种疫苗的个体相比(例如肌肉疼痛:OR = 1.23, 95% CI: 0.91-1.67)。结论对于大多数16-65岁的个体,我们没有发现COVID-19疫苗接种后急性后症状的证据。然而,接种过疫苗的人更有可能报告大多数症状,这可能是由于报告偏倚或反安慰剂效应。
{"title":"Post-acute non-specific symptoms following COVID-19 vaccination: a Danish population-based study","authors":"Christina Bisgaard Jensen, Kristoffer Torp Hansen, Bodil Hammer Bech, Stefan Nygaard Hansen, Henrik Nielsen, Charlotte Ulrikka Rask, Per Fink, Thomas Meinertz Dantoft, Torben Jørgensen, Jeremy A Labrecque, Sanne Møller Thysen, Dorte Rytter","doi":"10.1093/ije/dyaf173","DOIUrl":"https://doi.org/10.1093/ije/dyaf173","url":null,"abstract":"Background Post-acute non-specific symptoms such as headaches, muscular pain, and fatigue are frequently reported following COVID-19 vaccination, raising concerns about adverse events. As vaccine-hesitant individuals may be more likely to experience symptoms of vaccines, this study investigates whether COVID-19 vaccination increases the odds of post-acute non-specific symptoms, stratified by COVID-19 vaccine hesitancy. Methods This longitudinal study uses repeated measurements from the BiCoVac cohort—a random sample of 913 116 Danish citizens aged 16–65 years. Data were collected through national registers and questionnaires (May 2021–June 2022). Non-specific symptoms were identified by using the 25-item Bodily Distress Syndrome checklist and analysed by using logistic and linear regression models comparing vaccinated and unvaccinated individuals. Models were fitted with robust standard errors and inverse probability of selection weights. Results A total of 132 776 observations were collected from 61 316 COVID-19 vaccine-unconcerned individuals, 52 325 observations from 25 272 COVID-19 vaccine-sceptical individuals, and 10 242 observations from 5064 COVID-19 vaccine-concerned individuals. Among the vaccine-unconcerned individuals, those vaccinated had lower odds of most symptoms compared with unvaccinated individuals >4 weeks post-vaccination [e.g. muscular pain: odds ratio (OR) = 0.56, 95% confidence interval (CI): 0.47–0.68]. A similar tendency was found for vaccine-sceptical individuals, although with attenuated estimates. Conversely, among vaccine-concerned individuals, we observed a tendency for higher odds of most symptoms >4 weeks post-vaccination compared with unvaccinated individuals (e.g. muscular pain: OR = 1.23, 95% CI: 0.91–1.67). Conclusion For most individuals aged 16–65 years, we found no evidence of post-acute symptoms after COVID-19 vaccination. Vaccinated vaccine-concerned individuals were, however, more likely to report most symptoms, potentially due to reporting bias or nocebo effects.","PeriodicalId":14147,"journal":{"name":"International journal of epidemiology","volume":"110 1","pages":""},"PeriodicalIF":7.7,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145260663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between shingles and coronavirus disease 2019: a self-controlled case series study 带状疱疹与2019冠状病毒病的关系:一项自我对照病例系列研究
IF 7.7 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-09-26 DOI: 10.1093/ije/dyaf162
Tomoki Mizuno, Jun Suzuki, Shota Takahashi, Haruka Imai, Hideya Itagaki, Tomohiro Akaba, Makiko Yoshida, Shiro Endo
Background Although some studies suggest an increased risk of shingles following coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, no research has examined this relationship in real-world clinical settings. We aimed to investigate the association between shingles and COVID-19 by using a Japanese inpatient and outpatient claims database. Methods We identified patients with COVID-19 from 1 January 2020 to 30 January 2023 by using a Japanese inpatient and outpatient claims database. We also identified those who developed shingles and received antiviral drugs within 90 days before or after their COVID-19 diagnosis. Using self-controlled case series methods, we evaluated the relationship between shingles and COVID-19. We calculated the incidence rate ratio (IRR) [95% confidence interval (CI)] for shingles during the buffer period (days –35 to –7), pre-exposure period (days –6 to 0), and risk periods of the first and second, third and fourth, and fifth and sixth weeks following COVID-19 infection compared with a control period outside these intervals. Results Among 399 381 patients with COVID-19, 558 were diagnosed with shingles. The IRR was significantly elevated during the first and second (5.1, 95% CI 3.9–6.6), third and fourth (1.7, 95% CI 1.2–2.5), and fifth and sixth weeks (1.5, 95% CI 1.0–2.3) compared with a control period. Conclusion This study of a Japanese inpatient and outpatient database reveals a relationship between shingles and COVID-19, indicating that shingles may be a characteristic of the virus and highlighting the need for varicella-zoster vaccination alongside SARS-CoV-2 in the COVID-19 era.
虽然一些研究表明,由严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)感染引起的2019冠状病毒病(COVID-19)后带状疱疹的风险增加,但没有研究在现实世界的临床环境中检验这种关系。我们的目的是通过使用日本住院和门诊索赔数据库来调查带状疱疹和COVID-19之间的关系。方法利用日本住院和门诊索赔数据库,对2020年1月1日至2023年1月30日期间的COVID-19患者进行鉴定。我们还确定了那些在COVID-19诊断前后90天内患带状疱疹并接受抗病毒药物治疗的患者。采用自我控制病例系列方法,我们评估了带状疱疹与COVID-19之间的关系。我们计算了缓冲期(-35天至-7天)、暴露前期(-6天至0天)以及COVID-19感染后第一、第二、第三、第四、第五和第六周的危险期与这些间隔之外的对照期的带状疱疹发病率比(IRR)[95%置信区间(CI)]。结果399 381例新冠肺炎患者中,带状疱疹确诊558例。与对照期相比,IRR在第一和第二周(5.1,95% CI 3.9-6.6)、第三和第四周(1.7,95% CI 1.2-2.5)和第五和第六周(1.5,95% CI 1.0-2.3)显著升高。结论对日本住院和门诊患者数据库的研究揭示了带状疱疹与COVID-19之间的关系,表明带状疱疹可能是该病毒的一个特征,并强调在COVID-19时代需要在接种SARS-CoV-2的同时接种水痘-带状疱疹疫苗。
{"title":"Relationship between shingles and coronavirus disease 2019: a self-controlled case series study","authors":"Tomoki Mizuno, Jun Suzuki, Shota Takahashi, Haruka Imai, Hideya Itagaki, Tomohiro Akaba, Makiko Yoshida, Shiro Endo","doi":"10.1093/ije/dyaf162","DOIUrl":"https://doi.org/10.1093/ije/dyaf162","url":null,"abstract":"Background Although some studies suggest an increased risk of shingles following coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, no research has examined this relationship in real-world clinical settings. We aimed to investigate the association between shingles and COVID-19 by using a Japanese inpatient and outpatient claims database. Methods We identified patients with COVID-19 from 1 January 2020 to 30 January 2023 by using a Japanese inpatient and outpatient claims database. We also identified those who developed shingles and received antiviral drugs within 90 days before or after their COVID-19 diagnosis. Using self-controlled case series methods, we evaluated the relationship between shingles and COVID-19. We calculated the incidence rate ratio (IRR) [95% confidence interval (CI)] for shingles during the buffer period (days –35 to –7), pre-exposure period (days –6 to 0), and risk periods of the first and second, third and fourth, and fifth and sixth weeks following COVID-19 infection compared with a control period outside these intervals. Results Among 399 381 patients with COVID-19, 558 were diagnosed with shingles. The IRR was significantly elevated during the first and second (5.1, 95% CI 3.9–6.6), third and fourth (1.7, 95% CI 1.2–2.5), and fifth and sixth weeks (1.5, 95% CI 1.0–2.3) compared with a control period. Conclusion This study of a Japanese inpatient and outpatient database reveals a relationship between shingles and COVID-19, indicating that shingles may be a characteristic of the virus and highlighting the need for varicella-zoster vaccination alongside SARS-CoV-2 in the COVID-19 era.","PeriodicalId":14147,"journal":{"name":"International journal of epidemiology","volume":"2 1","pages":""},"PeriodicalIF":7.7,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145154123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the effectiveness of the human papillomavirus vaccination programme in England, using a regression discontinuity design 使用回归不连续设计评估英国人乳头瘤病毒疫苗接种计划的有效性
IF 7.7 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-09-24 DOI: 10.1093/ije/dyaf156
Isobel L Ward, Charlotte R Bermingham, Kate Soldan, Vahé Nafilyan
Background In England, the national human papillomavirus (HPV) immunization programme was introduced in 2008 to prevent cervical cancer. Girls aged 12–13 years were offered routine vaccination and those aged 14–18 years in 2008 were offered ‘catch-up’ vaccination. We evaluate the effect of the HPV catch-up vaccination programmes on cervical cancer and cervical dysplasia diagnoses, and provide an estimate of the vaccine effectiveness. Methods Using the 2011 Census, Hospital Episode Statistics, and mortality data for the population of England, we exploit the cut-off in eligibility and apply a regression discontinuity design to assess the impact of HPV vaccination on cervical disease. Results Vaccination reduced the incidence of cervical dysplasia and cancer diagnoses by 31% and 75%, respectively, at ages 23–30 years in girls offered catch-up vaccination at ages 17–18 years compared with those who were just above the eligibility age for the catch-up vaccination, with a clear discontinuity. Reductions continued amongst girls offered routine vaccination. Conclusion These estimates, obtained by using a quasi-experimental approach, are similar to vaccine effectiveness estimates based on more traditional approaches. This approach provides further evidence of the HPV vaccination programme reducing adverse cervical outcomes in young women and could be used for future studies to evaluate major changes in HPV vaccination policy and for studies of longer-term outcomes including other cancers and deaths.
背景:英国于2008年推出了全国人乳头瘤病毒(HPV)免疫规划,以预防宫颈癌。为12-13岁的女孩提供常规疫苗接种,2008年为14-18岁的女孩提供“补种”疫苗接种。我们评估了HPV补种疫苗计划对宫颈癌和宫颈发育不良诊断的影响,并提供了疫苗有效性的估计。方法使用2011年英国人口普查、医院事件统计和死亡率数据,我们利用资格的截止点,并应用回归不连续设计来评估HPV疫苗接种对宫颈疾病的影响。结果在17-18岁接种补种疫苗的女孩中,23-30岁的宫颈发育不良和癌症诊断率分别比刚好超过补种年龄的女孩低31%和75%,具有明显的不连续性。接受常规疫苗接种的女孩继续减少。结论使用准实验方法获得的这些估计值与基于更传统方法的疫苗有效性估计值相似。该方法为HPV疫苗接种规划减少年轻女性的不良子宫颈结局提供了进一步的证据,并可用于未来的研究,以评估HPV疫苗接种政策的重大变化,以及研究包括其他癌症和死亡在内的长期结局。
{"title":"Evaluating the effectiveness of the human papillomavirus vaccination programme in England, using a regression discontinuity design","authors":"Isobel L Ward, Charlotte R Bermingham, Kate Soldan, Vahé Nafilyan","doi":"10.1093/ije/dyaf156","DOIUrl":"https://doi.org/10.1093/ije/dyaf156","url":null,"abstract":"Background In England, the national human papillomavirus (HPV) immunization programme was introduced in 2008 to prevent cervical cancer. Girls aged 12–13 years were offered routine vaccination and those aged 14–18 years in 2008 were offered ‘catch-up’ vaccination. We evaluate the effect of the HPV catch-up vaccination programmes on cervical cancer and cervical dysplasia diagnoses, and provide an estimate of the vaccine effectiveness. Methods Using the 2011 Census, Hospital Episode Statistics, and mortality data for the population of England, we exploit the cut-off in eligibility and apply a regression discontinuity design to assess the impact of HPV vaccination on cervical disease. Results Vaccination reduced the incidence of cervical dysplasia and cancer diagnoses by 31% and 75%, respectively, at ages 23–30 years in girls offered catch-up vaccination at ages 17–18 years compared with those who were just above the eligibility age for the catch-up vaccination, with a clear discontinuity. Reductions continued amongst girls offered routine vaccination. Conclusion These estimates, obtained by using a quasi-experimental approach, are similar to vaccine effectiveness estimates based on more traditional approaches. This approach provides further evidence of the HPV vaccination programme reducing adverse cervical outcomes in young women and could be used for future studies to evaluate major changes in HPV vaccination policy and for studies of longer-term outcomes including other cancers and deaths.","PeriodicalId":14147,"journal":{"name":"International journal of epidemiology","volume":"2 1","pages":""},"PeriodicalIF":7.7,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145127772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Confounding mechanisms and adjustment strategies in air pollution epidemiology: a case study assessment with the UK Biobank cohort. 空气污染流行病学中的混淆机制和调整策略:英国生物银行队列的案例研究评估。
IF 5.9 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-08-18 DOI: 10.1093/ije/dyaf163
Jacopo Vanoli, Lina Madaniyazi, Massimo Stafoggia, Chris Fook Sheng Ng, Antonio Gasparrini

Background: Cohort studies are instrumental in examining long-term risks associated with environmental exposures but require appropriate control for various confounding effects. In this contribution, we assessed this issue by investigating the relationship between fine particulate matter (PM2.5) exposure and mortality in a UK-based cohort.

Methods: We analysed data from half a million adults in the UK Biobank linked with time-varying individual-level exposure data and followed up during the period 2006-21. The assessment focused on confounding related to spatial and temporal patterns as well as due to measurable variables, including both contextual and individual-level factors. We performed an evaluation consisting of descriptive analyses, specification and interpretation of direct acyclic graphs (DAGs), and comparison of results from survival models.

Results: We found correlations between PM2.5 exposure and mortality rates across time, geographical areas, and categories of measurable variables. The DAG indicated complex causal pathways and the need to adjust for a wide set of potential confounders. The regression analysis confirmed these patterns: the fully adjusted model estimated a hazard ratio (HR) of 1.25 (95% CI: 1.06-1.49) per 10 μg/m3 increments in PM2.5, but the association reversed to 0.82 (0.76-0.87) when excluding control for recruitment centre, suggesting strong spatial confounding. Calendar time showed stronger confounding effects compared to age. Area-level socio-economic indicators were more important than individual-level counterparts, while lack of control for lifestyle factors led to a noticeable overestimation.

Conclusions: This case-study illustration elucidates various confounding mechanisms in cohort studies on environmental risks and offers a critical evaluation of alternative adjustment strategies.

背景:队列研究有助于检查与环境暴露相关的长期风险,但需要适当控制各种混杂效应。在这篇文章中,我们通过调查细颗粒物(PM2.5)暴露与英国队列死亡率之间的关系来评估这一问题。方法:我们分析了英国生物银行中50万成年人的数据,这些数据与随时间变化的个人暴露数据有关,并在2006-21年期间进行了随访。评估的重点是与空间和时间格局有关的混淆以及可测量变量,包括环境因素和个人因素。我们进行了一项评估,包括描述性分析,直接无环图(dag)的说明和解释,以及生存模型结果的比较。结果:我们发现PM2.5暴露与死亡率在不同时间、地理区域和可测量变量类别之间存在相关性。DAG显示了复杂的因果途径,需要对广泛的潜在混杂因素进行调整。回归分析证实了这些模式:完全调整模型估计PM2.5每增加10 μg/m3,风险比(HR)为1.25 (95% CI: 1.06-1.49),但当排除招募中心的控制时,相关系数逆转为0.82(0.76-0.87),表明空间混淆很强。与年龄相比,日历时间显示出更强的混淆效应。地区一级的社会经济指标比个人一级的指标更重要,而由于缺乏对生活方式因素的控制,导致明显的高估。结论:本案例研究阐明了环境风险队列研究中的各种混淆机制,并提供了替代调整策略的关键评估。
{"title":"Confounding mechanisms and adjustment strategies in air pollution epidemiology: a case study assessment with the UK Biobank cohort.","authors":"Jacopo Vanoli, Lina Madaniyazi, Massimo Stafoggia, Chris Fook Sheng Ng, Antonio Gasparrini","doi":"10.1093/ije/dyaf163","DOIUrl":"10.1093/ije/dyaf163","url":null,"abstract":"<p><strong>Background: </strong>Cohort studies are instrumental in examining long-term risks associated with environmental exposures but require appropriate control for various confounding effects. In this contribution, we assessed this issue by investigating the relationship between fine particulate matter (PM2.5) exposure and mortality in a UK-based cohort.</p><p><strong>Methods: </strong>We analysed data from half a million adults in the UK Biobank linked with time-varying individual-level exposure data and followed up during the period 2006-21. The assessment focused on confounding related to spatial and temporal patterns as well as due to measurable variables, including both contextual and individual-level factors. We performed an evaluation consisting of descriptive analyses, specification and interpretation of direct acyclic graphs (DAGs), and comparison of results from survival models.</p><p><strong>Results: </strong>We found correlations between PM2.5 exposure and mortality rates across time, geographical areas, and categories of measurable variables. The DAG indicated complex causal pathways and the need to adjust for a wide set of potential confounders. The regression analysis confirmed these patterns: the fully adjusted model estimated a hazard ratio (HR) of 1.25 (95% CI: 1.06-1.49) per 10 μg/m3 increments in PM2.5, but the association reversed to 0.82 (0.76-0.87) when excluding control for recruitment centre, suggesting strong spatial confounding. Calendar time showed stronger confounding effects compared to age. Area-level socio-economic indicators were more important than individual-level counterparts, while lack of control for lifestyle factors led to a noticeable overestimation.</p><p><strong>Conclusions: </strong>This case-study illustration elucidates various confounding mechanisms in cohort studies on environmental risks and offers a critical evaluation of alternative adjustment strategies.</p>","PeriodicalId":14147,"journal":{"name":"International journal of epidemiology","volume":"54 5","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12448834/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145091543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The joint impact of greenspace and air pollution on mortality: a nationwide study in Finland. 绿色空间和空气污染对死亡率的共同影响:芬兰的一项全国性研究。
IF 5.9 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-08-18 DOI: 10.1093/ije/dyaf124
Matti Koivuranta, Marko Korhonen, Ina Rissanen

Background: Greenspace has been linked to reduced mortality while air pollution has been associated with increased mortality. We examined whether the joint association of greenspace and air pollution on mortality varies across ages, sexes, educational levels, urban and rural environments, and differential levels of both exposures in a nationwide population of Finland.

Methods: This study utilized routinely collected individual-level register data from Statistics Finland encompassing all citizens aged 30 years or older in 2000 (N = 3 003 519), followed until 2019. Greenspace was measured using the Enhanced Vegetation Index (EVI), and air pollution by the concentration of fine particulate matter ≤2.5 µm (PM2.5). Cox proportional hazards models were used to assess linear and non-linear associations between EVI, PM2.5, and mortality. Age was modeled flexibly with a natural cubic spline with four knots. Analyses were stratified by sex, educational level, and urbanicity.

Results: Both EVI and PM2.5 were independently associated with mortality (EVI: HR 0.99; 95% CI: 0.98-0.99 per IQR; PM2.5: HR 1.02; 95% CI: 1.01-1.03), with evidence of an interaction between the two (EVI × PM2.5: HR 0.99; 95% CI: 0.99-0.99). The joint association varied across age, sex, education, urbanicity, and the level of both exposures. PM2.5 was primarily linearly associated with increased mortality, accounting for EVI. In contrast, the relationship between EVI and mortality was less linear and more variable.

Conclusions: Expanding greenspace may be most beneficial in areas where it is limited and where air pollution levels are high.

背景:绿色空间与降低死亡率有关,而空气污染与增加死亡率有关。我们研究了绿地和空气污染对死亡率的联合关联是否因年龄、性别、教育水平、城市和农村环境的不同而不同,以及芬兰全国人口中两者暴露的不同水平。方法:本研究使用芬兰统计局常规收集的个人层面登记数据,包括2000年所有30岁及以上的公民(N = 3 003 519),随访至2019年。采用增强植被指数(Enhanced Vegetation Index, EVI)测量绿地面积,细颗粒物浓度≤2.5µm (PM2.5)测量空气污染。Cox比例风险模型用于评估EVI、PM2.5和死亡率之间的线性和非线性关联。采用四节自然三次样条灵活建模。分析按性别、教育水平和城市化程度进行分层。结果:EVI和PM2.5与死亡率独立相关(EVI: HR 0.99; 95% CI: 0.98-0.99 / IQR; PM2.5: HR 1.02; 95% CI: 1.01-1.03),两者之间存在相互作用(EVI × PM2.5: HR 0.99; 95% CI: 0.99-0.99)。这种联合关联因年龄、性别、教育程度、城市化程度和两种暴露水平而异。PM2.5主要与死亡率增加呈线性关系,并与EVI相关。相比之下,EVI和死亡率之间的关系不是线性的,而是可变的。结论:在绿地有限和空气污染水平高的地区,扩大绿地可能是最有益的。
{"title":"The joint impact of greenspace and air pollution on mortality: a nationwide study in Finland.","authors":"Matti Koivuranta, Marko Korhonen, Ina Rissanen","doi":"10.1093/ije/dyaf124","DOIUrl":"https://doi.org/10.1093/ije/dyaf124","url":null,"abstract":"<p><strong>Background: </strong>Greenspace has been linked to reduced mortality while air pollution has been associated with increased mortality. We examined whether the joint association of greenspace and air pollution on mortality varies across ages, sexes, educational levels, urban and rural environments, and differential levels of both exposures in a nationwide population of Finland.</p><p><strong>Methods: </strong>This study utilized routinely collected individual-level register data from Statistics Finland encompassing all citizens aged 30 years or older in 2000 (N = 3 003 519), followed until 2019. Greenspace was measured using the Enhanced Vegetation Index (EVI), and air pollution by the concentration of fine particulate matter ≤2.5 µm (PM2.5). Cox proportional hazards models were used to assess linear and non-linear associations between EVI, PM2.5, and mortality. Age was modeled flexibly with a natural cubic spline with four knots. Analyses were stratified by sex, educational level, and urbanicity.</p><p><strong>Results: </strong>Both EVI and PM2.5 were independently associated with mortality (EVI: HR 0.99; 95% CI: 0.98-0.99 per IQR; PM2.5: HR 1.02; 95% CI: 1.01-1.03), with evidence of an interaction between the two (EVI × PM2.5: HR 0.99; 95% CI: 0.99-0.99). The joint association varied across age, sex, education, urbanicity, and the level of both exposures. PM2.5 was primarily linearly associated with increased mortality, accounting for EVI. In contrast, the relationship between EVI and mortality was less linear and more variable.</p><p><strong>Conclusions: </strong>Expanding greenspace may be most beneficial in areas where it is limited and where air pollution levels are high.</p>","PeriodicalId":14147,"journal":{"name":"International journal of epidemiology","volume":"54 5","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144953572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cohort Profile Update: The Irish Longitudinal Study on Ageing (TILDA)-Waves 5 and 6. 队列概况更新:爱尔兰老龄化纵向研究(TILDA)-第5和第6波。
IF 5.9 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-08-18 DOI: 10.1093/ije/dyaf158
Siobhan Scarlett, Ann Monaghan, Sinead McLoughlin, Ann Hever, Cathal McCrory, Mark Ward, Christine A McGarrigle, Rose Anne Kenny
{"title":"Cohort Profile Update: The Irish Longitudinal Study on Ageing (TILDA)-Waves 5 and 6.","authors":"Siobhan Scarlett, Ann Monaghan, Sinead McLoughlin, Ann Hever, Cathal McCrory, Mark Ward, Christine A McGarrigle, Rose Anne Kenny","doi":"10.1093/ije/dyaf158","DOIUrl":"10.1093/ije/dyaf158","url":null,"abstract":"","PeriodicalId":14147,"journal":{"name":"International journal of epidemiology","volume":"54 5","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12476908/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145185831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What would we learn from empirical evaluations of epidemiologic methods? 我们能从流行病学方法的经验评估中学到什么?
IF 5.9 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-08-18 DOI: 10.1093/ije/dyaf155
Jeremy A Labrecque
{"title":"What would we learn from empirical evaluations of epidemiologic methods?","authors":"Jeremy A Labrecque","doi":"10.1093/ije/dyaf155","DOIUrl":"https://doi.org/10.1093/ije/dyaf155","url":null,"abstract":"","PeriodicalId":14147,"journal":{"name":"International journal of epidemiology","volume":"54 5","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144953524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International journal of epidemiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1